PMID: 5467162 [PubMed - indexed for MEDLINE] MeSH Terms In each case amenorrhea resolved when spironolactone therapy was discontinued.

1992 Jul;121(1):141-3. doi: 10.1016/s0022-3476(05)82562-4.Concours Med. Nach oraler Gabe liegt die Bioverfügbarkeit von Spironolacton bei mehr als 90%. The visceral type of obesity and disorders of menstrual cycle were observed in all patients: oligomenorrhea was observed in 9 (52.9%), amenorrhea in … All Rights Reserved 1970;211(12):2014-2015. doi:10.1001/jama.1970.03170120058015© 2020 American Medical Association. In each case amenorrhea resolved when spironolactone therapy was discontinued. Discontinuation of therapy resulted in normal menstrual periods within two months in every patient. 1970 Mar 23;211(12):2014-5. 1974 Mar 9;96(10):1559-60, 1563-4, 1567-8.Indian J Chest Dis Allied Sci. ORILISSA 150 mg dose didn't show a significant difference in reported pain with sex compared with placebo (a pill with no active medicine). Spironolacton führt über eine Blockade der Aldosteron-Rezeptoren zu einer vermehrten Ausscheidung von Natrium und Wasser. Hemat:agranulocytosis, thrombocytopenia. Silverchair Information Systems Our website uses cookies to enhance your experience.
The high incidence of amenorrhea in this group may be due to increased drug susceptibility or decreased drug elimination in patients with kidney disease.Customize your JAMA Network experience by selecting one or more topics from the list below.From the Department of Internal Medicine, University of Minnesota Medical School, Minneapolis. In each case amenorrhea resolved when spironolactone therapy was discontinued. The high incidence of amenorrhea in this group may be due to increased drug susceptibility or decreased drug elimination in patients with kidney disease.Customize your JAMA Network experience by selecting one or more topics from the list below.From the Department of Internal Medicine, University of Minnesota Medical School, Minneapolis. Silverchair Information Systems Dive into the research topics of 'Primary and secondary amenorrhea associated with spironolactone therapy in chronic liver disease'. First-line agents include spironolactone (Aldactone)22, 23, 28 – 30 and metformin,13, 16, 20, 22, 31 – 33 as well as eflornithine (Vaniqa) for facial hirsutism.9 1993 Dec;16(11):925-32. doi: 10.1007/BF03348960.Br J Clin Pharmacol. ORILISSA® (elagolix) treats 3 common endometriosis symptoms: painful periods, pelvic pain in between periods, and pain with sex.

The drug action causing this side effect may be responsible for previously reported gynecomastia, but this … By continuing you agree to the JAMA. Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder that appears to emerge at puberty. COVID-19 is an emerging, rapidly evolving situation. FA 2014, p591: "ketoconazole and spironolactone are used in the treatment of PCOS to prevent hirsutism. The drug action causing this side effect may be responsible for previously reported gynecomastia, but this action is unknown. All Rights Reserved 1970;211(12):2014-2015. doi:10.1001/jama.1970.03170120058015© 2020 American Medical Association. sign up for alerts, and moreto access your subscriptions, sign up for alerts, and moreto access your subscriptions, sign up for alerts, and moreto download free article PDFs, sign up for alerts, customize your interests, and moreto make a comment, download free article PDFs, sign up for alerts and more Primary and secondary amenorrhea associated with spironolactone therapy in chronic liver diseasePrimary and secondary amenorrhea associated with spironolactone therapy in chronic liver diseasePrimary and secondary amenorrhea associated with spironolactone therapy in chronic liver disease Der Wirkstoff Spironolacton ist zugelassen für die Behandlung von Wassereinlagerungen (Ödemen) und zu hohe Aldosteron-Blutspiegel, die sich klinisch durch Bluthochdruck und niedrige Kaliumwerte im Blut äußern können. All Rights Reserved.to download free article PDFs, We suggest that spironolactone, an androgen inhibitor, may also cause reversible amenorrhea.UR - http://www.scopus.com/inward/record.url?scp=0026751708&partnerID=8YFLogxKUR - http://www.scopus.com/inward/citedby.url?scp=0026751708&partnerID=8YFLogxK"We use cookies to help provide and enhance our service and tailor content. eCollection 2014.J Endocrinol Invest. We suggest that spironolactone, an androgen inhibitor, may also cause reversible amenorrhea.T1 - Primary and secondary amenorrhea associated with spironolactone therapy in chronic liver diseaseN2 - Women with severe liver disease often have amenorrhea that resolves as liver disease abates.
1. We describe three patients with mild to moderate chronic liver disease and amenorrhea. 1987 Jan-Mar;29(1):63-4.Ann Intern Med. Spironolacton blockiert in den Sammelrohren der Niere die Bindung des Mineralkortikoids Aldosteron an seinen Rezeptor.

By continuing to use our site, or clicking "Continue," you are agreeing to our 2020 American Medical Association. ORILISSA 150 mg dose didn't show a significant difference in reported pain with sex compared with placebo (a pill with no active medicine). We describe three patients with mild to moderate chronic liver disease and amenorrhea. Für Erwachsene wird eine Initialdosis von 100-200 mg Spironolacton pro Tag empfohlen. Unable to load your delegates due to an error The high incidence of amenorrhea …